Full Report

Figures converted from INR to USD at historical FX rates (frankfurter.app). Monetary statements are shown in US$ millions; per-share figures use the matching period rate. Filing links open the native figures from which each USD value was derived.

As-reported financial statements for Nuvama Wealth Management Limited, FY2022–FY2025, traced to the source filings, opened with the share-price history those statements have to justify. Every linked USD figure opens the exact filing row containing the native reported value from which it was converted. Amounts in US$ millions unless noted.

Share Price — Full Available History — 3 Years

The stock closed at $20.27 on Jul 09, 2026 — down 28% over the window shown (-11.5% a year), trading between $12.31 and $96.80. At that close the stock trades at 6.8× FY2025 diluted EPS as reported below.

Source: market price feed, weekly closes, sampled from 680 source observations, Oct 2023–Jul 2026. Price return only, excludes dividends. Prices converted from INR to USD with date-matched or nearest-available FX.

FY2025 at a Glance

Source: FY2025 consolidated statements [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Revenue by Business Segment

Revenue by Business Segment	FY2022	FY2023	FY2024	FY2025
Wealth management business	154	205	225	255
Asset management business	3	6	11	14
Capital market business	83	84	158	230
Unallocated	0	2	1	48
Total segment revenue	240	297	394	546
Inter-segment eliminations	(24)	(29)	(26)	(82)
Total revenue (incl. other income)	216	268	369	464
Total revenue (incl. other income) growth, derived	—	+24.0%	+37.6%	+25.8%

Source: Note 43/46 Segment Reporting — segment revenue (gross, before inter-segment eliminations) [5] [6] [7]. Click any linked figure to open the filing page with the row highlighted.

Segment Profit / (Loss) Before Tax

Segment Profit / (Loss) Before Tax	FY2022	FY2023	FY2024	FY2025
Wealth management business	19	36	42	47
Asset management business	(2)	(1)	(1)	(1)
Capital market business	20	15	58	100
Unallocated	0	0	(5)	47
Total segment result	37	50	94	193

Source: Note 43/46 Segment Reporting — segment result before taxation [5] [6] [7]. Click any linked figure to open the filing page with the row highlighted.

Income Statement

Income Statement	FY2022	FY2023	FY2024	FY2025	FY2026E	FY2027E
Interest income	62	79	130	191	—	—
Fee and commission income	128	159	202	238	—	—
Net gain on fair value changes	25	28	30	33	—	—
Total revenue from operations	215	266	368	463	380	441
Other income	1	2	1	1	—	—
Total income	216	268	369	464	—	—
Finance costs	34	48	72	91	—	—
Employee benefits expense	73	88	104	130	—	—
Total expenses	179	219	274	318	—	—
Profit before tax	113	49	95	147	—	—
Profit for the year	104	37	73	110	—	—
Profit attributable to owners of the Company	104	37	73	110	—	—
Basic earnings per share (Rs.)	6.04	1.11	2.08	3.08	—	—
Diluted earnings per share (Rs.)	2.96	1.11	2.03	2.99	0.71	0.84
Total revenue from operations growth, derived	—	+24.1%	+38.3%	+25.8%	-17.9%	+16.1%

Source: Consolidated Statement of Profit and Loss (Ind AS) [1] [2] [3] [4]. Click any linked figure to open the filing page with the row highlighted.

Columns marked E are consensus analyst estimates shown alongside reported results for direct comparison; they are not company guidance.

Estimate source: Yahoo Finance analyst consensus, as of 2026-07-10. Forecasts carry no filing page links.

Balance Sheet

Balance Sheet	FY2022	FY2023	FY2024	FY2025
Cash and cash equivalents	121	95	43	59
Bank balances other than cash and cash equivalents	454	546	1,430	2,193
Securities held for trading	108	157	86	160
Trade receivables	108	107	77	83
Loans	357	427	568	512
Total assets	1,282	1,528	2,381	3,160
Trade payables (creditors other than micro small enterprises)	198	210	427	671
Debt securities	388	560	657	749
Borrowings (other than debt securities)	40	89	131	123
Total liabilities	1,051	1,257	2,043	2,771
Total equity	231	272	339	389

Source: Consolidated Balance Sheet (Ind AS) [8] [9] [10]. Click any linked figure to open the filing page with the row highlighted.

Cash Flow

Cash Flow	FY2022	FY2023	FY2024	FY2025
Profit before tax	113	49	95	147
Net cash used in operating activities	(172)	(224)	(194)	(41)
Purchase of property, plant, equipment and intangibles	(6)	(9)	(9)	(4)
Net cash generated from financing activities	259	219	154	67
Dividend paid on equity shares	—	—	—	(57)
Net increase / (decrease) in cash and cash equivalents	77	(26)	(49)	18
Free cash flow, derived	(179)	(234)	(203)	(45)

Source: Consolidated Statement of Cash Flows (Ind AS) [11] [12] [13] [14]. Click any linked figure to open the filing page with the row highlighted.

Long-Term Record

Fiscal year	Total income	Profit before tax	Profit for the year	Diluted earnings per share (Rs.)	Net cash used in operating activities	Total equity
FY2022	216	113	104	2.96	(172)	231
FY2023	268	49	37	1.11	(224)	272
FY2024	369	95	73	2.03	(194)	339
FY2025	464	147	110	2.99	(41)	389

Source: consolidated statements across filings; older years from the standardized feed [12] [1] [8] [14]. Click any linked figure to open the filing page with the row highlighted.

Traceability

181 of 193 figures on this page (94%) link to the filing page containing the native reported figure from which the USD value was converted — click a linked figure to open that source row. Unlinked figures come from standardized data feeds or pre-filing years.

• Consolidated figures are presented in Indian rupees in million exactly as printed in each annual report; display unit is ₹ millions.

• Fiscal year ends March 31 (e.g. FY2025 = year ended March 31, 2025). Nuvama was formerly Edelweiss Securities Limited (renamed 2022; listed 2023).

• FY2022 is the comparative column of the FY2023 annual report. FY2022 profit before tax (₹9,351.09m) and net profit (₹8,573.93m) include exceptional gains of ₹6,316.32m (reversal of provisions on investments in associate/subsidiary) and are not comparable to operating years.

• FY2022 EPS (basic ₹499.18 / diluted ₹244.60, from continuing operations) reflects a much smaller pre-listing share count plus the exceptional gains; not comparable to later years.

• Minor restatements exist between an annual report's own column and the following year's comparative column (e.g. FY2024 fee commission income 17,336.25 in the FY2024 AR vs 17,384.53 restated in the FY2025 AR). Each year uses figures from its own annual report; comparative-column values in a quote may differ slightly.

• Operating cash flow is negative in every year shown — characteristic of the broking/NBFC model (growth in client bank balances, loans and trading securities), funded largely by financing inflows.

• Revenue-by-segment 'Total revenue' reconciles to Total Income (including other income) after inter-segment eliminations, per the segment note.

• 3 figure(s) differed between the data feed and the filing; the filing value is shown (see the run's financials/financials_tab.json for the audit trail).

---

Figures converted from Indian rupees (INR) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

What Nuvama Is

Nuvama is an integrated Indian wealth-and-capital-markets firm carved out of Edelweiss, now controlled by private equity — PAG owns about 55% [1] — and in play again, with General Atlantic negotiating to buy that stake [2]. It earns high returns on a genuine structural tailwind, compounding operating profit at a 39% five-year CAGR to $117 million in FY26 [3]. But the shares sit at record levels near 34 times earnings, so a margin of safety is not the obvious feature here — it is the question.

The business: one platform, four engines

Nuvama oversees about $50.4 billion of client assets and serves 13 lakh-plus affluent and HNI clients plus 4,750-odd of India's wealthiest families, built over roughly 30 years under the Edelweiss and then Nuvama names [4]. The company runs one integrated platform across four businesses:

• Wealth Management — advisory, distribution, broking and lending against securities for two client tiers: Nuvama Private (UHNI and family offices) and Nuvama Wealth (HNI and affluent).
• Asset Services — custody, clearing and financing for FPIs, AIFs and professional investors; an infrastructure-like, annuity business.
• Capital Markets — institutional equities, investment banking, and a fast-growing fixed-income franchise.
• Asset Management — AIFs and PMS across public markets, private equity and commercial real estate; still sub-scale at $1.4 billion of AUM.

Sources: Q4 & FY26 earnings release [5] [6]; ROE derived from reported financials.

How it makes money — and where the profit actually sits

Nuvama earns three kinds of income: recurring fees and trail (ARR and managed-product distribution, the highest-quality line), transactional revenue (broking, banking, clearing), and net interest on a lending book (loans against securities, margin funding). FY26 consolidated revenue was $347 million, up 8%, and operating profit after tax was $117 million [7]. The five-year record is the strongest single fact about the company: revenue compounded at 26% and operating PAT at 39%, while the cost-to-income ratio fell from 70% to about 56% — growth plus operating leverage, not one at the expense of the other [8].

Source: Q4 FY26 investor presentation, five-year financial performance [9].

The composition matters more than the total. Wealth Management is the part the market pays a premium for — FY26 revenue of $191 million and PBT of $65 million, both up more than 20% [10]. Yet the larger profit pool is still Asset Services and Capital Markets, at $92 million of PBT in FY26 — and that pool shrank 3%, dragged by a 19% fall in capital-markets revenue as issuance and trading cooled [11]. So the headline "wealth manager" is only half the engine; the other half rides the market cycle, and it is the bigger half today.

Source: Q4 & FY26 earnings release; Asset Management/other is the residual to reported operating PBT of $154 million [12] [13].

The industry it sits in

The demand case is straightforward and well-evidenced. Financial assets are roughly 25% of household wealth in India against about 70% in the United States, so the shift from physical assets (property, gold) toward financial products has decades to run [14]. Wealth is also highly concentrated: roughly 35,000 UHNI households hold 70–75% of India's financial wealth, the exact segment Nuvama's Private arm targets [15]. Nuvama positions itself as the only listed pure-play wealth manager spanning both the UHNI and the HNI/affluent tiers [16]; whether that positioning is a durable moat or a good industry that many can enter is tested later against listed peers (360 ONE, Anand Rathi, Motilal Oswal, Angel One, IIFL).

Who owns it, and the deal in the background

Nuvama's ownership history is central to the case. Edelweiss built the wealth business; PAG, an Asia-Pacific private-equity firm, bought it from Edelweiss in 2020 for about $325 million, and the business was demerged from Edelweiss and listed on the NSE in September 2023 at $33 per share [17] [18]. PAG still holds about 55% [19]. As of mid-2026, General Atlantic is reported to be in advanced talks to acquire that controlling stake for roughly $1.82 billion — a transaction that both marks an arm's-length value on the whole company (around $3.4 billion) and hands control from one financial owner to another [20].

Two things follow for a value investor. First, "insider ownership" here means a private-equity sponsor, not a founder with skin in the game — a distinction that reshapes how alignment and capital allocation should be judged. Second, a change-of-control overhang sits over the stock, and the reported delay in the deal came down to price after the shares rallied.

The price, and what it implies

The stock has been anything but a fallen star. It listed at $33, ran to a split-adjusted peak near $18.8 in mid-2025 (a 1:5 split took effect in December 2025), corrected about 29% into March 2026, and has since recovered to fresh highs [21].

Source: NSE daily price series, adjusted for the 1:5 split and converted at historical FX rates; split confirmed per news reports [22].

At $20.27 (9 July 2026), Nuvama's roughly 186 million shares are worth about $3.8 billion — about 34 times trailing FY26 earnings and around 29 times the consensus FY27 estimate. That is a premium multiple for a company whose earnings grew 6% last year, and consensus price targets (mean $19.60) sit just below the current price. The mooted General Atlantic value of roughly $3.4 billion is below the market's mark. None of that is a verdict on quality; it is the arithmetic of what the buyer of the stock today is paying.

Source: derived from reported FY26 financials, NSE price data, and consensus estimates (as reported).

The through-line this report follows

The question this report exists to answer: does Nuvama's high-return, structurally-growing wealth franchise justify a premium multiple set near record highs — when control sits with private equity (PAG, now negotiating a sale to General Atlantic) rather than a founder, and a meaningful share of profit still rides the capital-markets cycle?

Everything that follows tests one part of that: the durability of the wealth economics and the moat behind them; whether the ownership and governance meet a value investor's bar; how much of the growth is structural versus cyclical; and where — at 34 times earnings and record levels — any margin of safety could come from.

---

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, yields, and multiples are unitless and unchanged.

The Wealth Engine

The wealth franchise is the part of Nuvama the premium multiple is meant to rest on, so its unit economics are worth taking apart. In FY26 the two wealth businesses — Nuvama Wealth (HNI/Affluent) and Nuvama Private (UHNI) — together earned $192.4 million of revenue and $65.6 million of profit before tax, up roughly 20% and 23% respectively [1]. The durable part — recurring managed-product and advisory fees — is compounding at 20–32% and now supplies the majority of wealth revenue. The offset is that most client assets still sit in low-yield transactional and broking balances, and blended yields keep drifting down.

The franchise revenue has more than tripled in five years, a ~29% compound rate, growing in every year through the last cycle.

Source: Q4 FY26 investor presentation, segmental revenue FY21–FY26 [2].

Two franchises, two different jobs

The label "wealth management" covers two businesses that scale differently. Nuvama Wealth serves 1.3 million-plus HNI and Affluent clients through ~1,100 relationship managers and ~8,000 external wealth managers, and closed FY26 with $12.0 billion of client assets [3]. Nuvama Private serves 4,750-plus UHNI families through just 145-plus bankers, and holds twice the assets — $23.1 billion [4]. Private is the larger asset pool run by a far smaller, higher-touch team; Wealth is the broader, more distribution-led book.

Source: Q4 FY26 investor presentation, Nuvama Wealth [5] and Nuvama Private performance metrics [6].

Both grew profit at a similar clip in FY26 — Nuvama Wealth PBT rose 23% to $37.0 million, Nuvama Private 24% to $28.7 million — but the paths differ. Wealth's revenue grew 17% to $107.5 million while its client assets rose 14%; Private's revenue grew 24% to $84.9 million while its client assets rose only 3.6% [7] [8]. Private's profit grew far faster than its assets — the tell that the earnings are coming from a mix shift, not from the headline asset number.

Sources: Q4 FY26 investor presentation, Nuvama Wealth [9] [10] and Nuvama Private [11] [12].

The mix shift toward recurring fees

The quality of these earnings is improving, and it shows up in the revenue mix. In Nuvama Wealth, managed products and investment solutions (MPIS) rose from 50% of revenue in FY25 to 59% in FY26, while brokerage fell from 17% to 11% [13]. In Nuvama Private, annual recurring revenue rose from 56% to 59%, with transactional revenue the balance [14]. The direction of travel is the same in both: away from one-off broking and toward fees that recur.

Source: Q4 FY26 investor presentation, Nuvama Wealth revenue composition [15]. MPIS = managed products and investment solutions; NII = net interest income on the lending book.

Management frames this as the strategic priority, and the flow data backs it: across the nine months to December 2025, MPIS revenue in Nuvama Wealth grew about 48% year-on-year and now contributes roughly 60% of wealth revenue [16]. New flows into recurring and MPIS assets ran at 25% of opening balances for the full year [17]. A book that adds a quarter of its recurring base in new money every year, and reinvests the mix toward fees that persist, is the compounding the wealth thesis needs.

The asset base that does the compounding

The headline asset numbers flatter the growth, because most client assets are not the assets that earn recurring fees. Separating the two is where the economics get honest.

In Nuvama Wealth, MPIS assets grew 32% to $4.4 billion and the lending book grew 76% to $552 million, while broking assets — the largest single slice at $6.9 billion — were essentially flat [18]. In Nuvama Private, ARR-earning assets grew 21.5% to $6.0 billion, but transactional assets — nearly two-thirds of the $23.1 billion total — grew about 1% [19]. The earning base is compounding in the low-20s to low-30s; the total is barely moving because the transactional and broking balances that make up the majority are market-linked and go sideways when markets do.

Source: Q4 FY26 investor presentation, Nuvama Wealth [20] and Nuvama Private client-asset composition [21].

This matters for how a reader should read the asset headline. Growth in recurring flows is the signal: MPIS net new money in Nuvama Wealth rose 38% to $999 million in FY26 [22]. But the counter is real and sits on the same page: Nuvama Private's recurring net new money actually fell 4.6% year-on-year, to $1.08 billion [23]. Management calls the quarterly figure noisy and points to full-year flows tracking ~25% of opening ARR assets [24]; the honest read is that the recurring engine is compounding fast but not yet in a straight line.

Yields: higher where it is managed, lower on the blend

The mix shift raises fee quality but not the blended yield, because the growing low-yield broking base drags the average down. On the managed and advisory assets the economics are attractive: Nuvama Private earns a blended retention of about 90 basis points on roughly $5.6 billion of average ARR assets [25], and managed products in Nuvama Wealth carry trail yields "1% plus" [26]. But on the total wealth book, management guides blended gross yield to settle at 70–80 basis points over the next few years [27], and yields have drifted from around 85 to 83 basis points, which management attributes to the broking-asset component whose mark-to-market moves without matching revenue rather than to structural pricing pressure [28].

The lending book is the other lever, and the most capital-intensive one. It grew from about $314 million to $482 million through the first nine months of FY26 as management deliberately re-expanded it after a year of tightening [29]. It adds net interest income but also balance-sheet risk: about a quarter of its funding comes from market-linked debentures whose hedging cost swings the quarterly spread, and RBI provisioning rules front-load a standard credit charge whenever the book grows [30]. This is the piece of the wealth franchise that behaves least like an asset-light fee compounder and most like a lender, and it is the natural place for a value investor to probe cash quality.

The people engine, still ramping

Wealth is a talent business, and Nuvama's operating leverage is still partly latent. In Nuvama Wealth, management paused hiring for three quarters to stabilise a base in which about 30% of relationship managers had under a year of tenure and were earning less than one times their fixed cost [31]. In Nuvama Private, the team grew about 10% over the year to roughly 150 bankers, with new locations and an offshore build-out in Dubai (now break-even) and Singapore [32]. A cohort of sub-scale RMs maturing toward productivity is a source of embedded margin — the same fixed cost carrying more revenue — but it is a promise of leverage, not yet delivered leverage.

Competition is the standing risk to all of this. Management itself flags private-equity-backed platforms building teams aggressively and pushing down from UHNI into the HNI and Affluent segments Nuvama occupies [33]. Whether the integrated platform and lending balance sheet are a durable moat or a good industry many can enter is a question for a later chapter; here it is enough to note that the fee yields underpinning these economics are being competed for.

What would change the read

The wealth franchise is a genuine compounder at the level that matters: recurring managed-product and advisory revenue is growing 20–48%, its share of the mix is rising, and it earns 90 basis points to over 1% on the assets it manages. That is the base a premium multiple can be built on, and it is improving in quality, not just in size.

Two facts keep the read measured. First, the majority of client assets are low-yield transactional and broking balances that move with markets, so headline AUM growth overstates the earning franchise — and Nuvama Private's recurring net new money fell in FY26. Second, the lending book that supplies part of the yield is capital-intensive and cyclical, and blended yields are guided lower. The read would strengthen if recurring net new money re-accelerated across both franchises and the maturing RM cohort lifted revenue per banker without a matching rise in cost; it would weaken if managed-product yields compressed under the competition management itself describes, or if the lending book had to be tightened again in a market drawdown. For a group whose largest profit pool still sits in the capital-markets cycle (What Nuvama Is), the durability of this recurring wealth engine is what the investment case leans on.

---

Ownership and Governance

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates (roughly ₹1 = $0.0117 for FY2024-25 and $0.0111 for FY2026/current). Ratios, margins, multiples, share counts, and percentages are unitless and unchanged.

Nuvama has never had a permanent owner. Control passed from the Edelweiss group to the private-equity firm PAG in 2020, and PAG — sitting on roughly a five-fold paper gain — is now in advanced talks to sell its ~54.8% stake to another financial sponsor, General Atlantic [1]. There is no founder in the register and no manager with a controlling stake. Governance itself is institutionally clean; the alignment a value investor screens for — durable, founder-style skin in the game — is simply not the model here.

A company that changes hands, not owners

The controlling stake in the wealth business was carved out of Edelweiss and bought by PAG in 2020 for about $325m [2]. PAG became the promoter, the business was demerged and listed in September 2023, and as of 31 March 2025 two PAG-controlled entities held 19,707,345 shares, or 54.78% of the company [3]. At the September 2023 listing the same promoter block was 55.29% [4]; the small drift down since is dilution from employee-option exercises, not a PAG selldown.

In June 2026, reports placed General Atlantic in advanced talks to buy PAG's ~54% controlling stake for about $1.82bn, with Morgan Stanley and JPMorgan advising, the process reportedly slowed by a valuation gap after the stock's rally [5]. Two implications matter for a prospective public shareholder. First, a change of control above the SEBI takeover threshold triggers a mandatory open offer to public holders for up to 26% of the company — an exit option at the offer price, but also confirmation that the buyer sets the reference mark, not the screen. Second, the reported ~$1.82bn for ~54.8% implies a whole-company value near $3.4bn, below the market capitalisation the shares carried in mid-2026 — the same gap flagged in What Nuvama Is, now with a named counterparty attached to it.

Source: compiled news, June–July 2026 [6]; FY2024-25 Annual Report, Shareholding Details [7].

Who owns the other 45%

Outside PAG, the register is institutional and dispersed. As of 31 March 2025, foreign portfolio investors held ~16.6%, mutual funds 4.6%, insurers and alternative funds another ~1.2%, domestic bodies corporate 3.3%, and retail-scale public holders 17.5% [8]. There is no second promoter, no founding family, and no employee trust of any size — the entire ~45.2% free float sits with financial investors.

Source: FY2024-25 Annual Report, Corporate Governance Report — Shareholding Details [9]. "Insurers, AIFs and other" groups insurance companies, AIF-III, HUFs, NRIs and trusts.

For a value investor who hunts fallen stars with strong insider ownership, this is the structural fact to sit with: the people running Nuvama do not, as a group, control it, and the people who control it are in the business of selling. That is not a governance defect — it is a different alignment model, and one worth naming plainly rather than scoring against a founder-owned template.

Management is aligned by pay and options, not by ownership

Ashish Kehair has led Nuvama as Managing Director and CEO since September 2021; Shiv Sehgal runs Capital Markets as Executive Director. Neither founded the business, and both are aligned the way professional managers of a sponsor-owned firm usually are — through cash-weighted variable pay and equity-settled options, not a controlling shareholding.

Source: FY2024-25 Annual Report, Corporate Governance Report — remuneration of Executive Directors [10]. Excludes one-time LTIP payouts ($0.29m Kehair; $0.17m Sehgal) granted in FY2021-22.

Kehair's FY25 package totalled about $1.13m, roughly two-thirds of it variable pay, with a one-time legacy LTIP of about $0.29m on top; Sehgal's totalled about $0.85m [11]. The CEO's pay ran at about 47 times the median employee's — high in absolute terms but not extreme for a capital-markets firm, and heavily performance-geared rather than fixed.

The equity link runs through options. Under the ESOP 2021 and SAR 2024 plans, about 1.91 million options and appreciation rights were outstanding at 31 March 2025 — near 5.3% of the then 35.97 million shares, though the appreciation rights settle only the gain, so net issuance is smaller [12]. The ESOP strike of about $15 sits deep in the money against a share price in the tens of dollars before the December 2025 split; the plans have been a genuine wealth event for senior staff [13]. Share-based-payment expense was modest against profit — about $3.7 million consolidated in FY25 — so the drag on earnings is small; the question is dilution and its timing, not the cost [14].

That timing is now live. In July 2026 the company put a fresh ESAR 2026 scheme — up to 1.37 crore rights — plus revised remuneration for Kehair and Sehgal to a postal ballot [15]. A large new employee-incentive pool and higher executive pay, arriving as control is about to change hands, is the kind of item a governance-minded reader tracks: it re-aligns the team a new sponsor will inherit, and it dilutes the public shareholder at the margin.

The governance framework itself holds up

Where the ownership model is unusual, the governance scaffolding is conventional and compliant. At the FY25 report date the board had eight directors: an independent non-executive chairperson, three other independent directors, two PAG nominees, and two executives — a majority non-executive board with the chair and CEO roles separated, a discretionary best practice the company adopted [16], each director's category set out in the board table [17]. The audit committee is chaired by an independent director, the statutory auditor (S.R. Batliboi & Co. LLP) issued an unmodified opinion, and the company reported no material related-party transactions in FY25 — all in the ordinary course and at arm's length [18].

Two textures are worth holding. Board turnover has been steady around the ownership question — two nominee directors and one independent director resigned across FY24–FY25, and a long-serving independent director's second term was set to end in April 2026 — so the board a new sponsor inherits is already in flux [19]. And the Edelweiss lineage lingers in the boardroom: an independent director also sits on Edelweiss-group boards such as ECL Finance and Edelweiss Asset Reconstruction [20]. Neither rises to a red flag on the record, but both are worth watching through the transition.

The solvency gate

This reader excludes companies that could go bankrupt, so the balance sheet earns a direct check. Nuvama is a leveraged financial — net debt was about $1.22bn against equity of about $459m at FY26, a debt-to-equity ratio near 2.8x, funding a margin-lending and clearing book rather than an operating deficit. What offsets the leverage is profitability and rating. Return on equity has run 22–28% over FY24–FY26, equity is compounding in the high teens to low twenties, and every rating agency carries the company at AA– — CRISIL and CARE at AA–/Stable with A1+ short-term, and ICRA at AA– with its outlook raised to Positive in FY25 [21].

Source: return on equity and debt/equity derived from reported financials, FY2024-26 [22]; credit ratings per FY2024-25 Annual Report.

An AA– issuer earning a mid-20s ROE is not a bankruptcy candidate on the current record. The genuine risk is second-order: the leverage funds a lending and clearing book whose quality through a severe drawdown is not yet tested at this size — a thread the report should still pull separately, since the rating agencies rate the entity, not any single stressed scenario.

What this means for a margin-of-safety buyer

On the specific screen this reader uses — a fallen star with strong founder or insider ownership — Nuvama does not fit. It is near record levels, not fallen; it is controlled by a private-equity seller, not a founder-owner; and management's stake is an option package, not a controlling holding. The offsetting evidence is real and should be weighed in the same breath: governance is clean and compliant, related-party dealings are immaterial, the balance sheet is investment-grade, and management does hold quarterly calls with the CEO presenting — the engagement discipline this reader values. What would change the read is the deal itself: General Atlantic's final price and structure would set an arm's-length mark for the whole company, and a founder-style lock-in or a sponsor committed to a longer hold would narrow the ownership gap that the screen, on today's facts, leaves open.

---

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged. Industry pools the company itself reports in US dollars are shown unchanged.

Industry and Rivals

Organized wealth under professional management in India reaches roughly 15% of financial wealth, against about 75% in mature markets, and the pools Nuvama competes for are set to roughly triple (wealth) and quintuple (alternatives) this decade [1] [2]. That is a genuine sunrise runway. But the same arithmetic draws capital: every listed rival earns 20-45% on equity, Nuvama's own filings flag intensifying competition for relationship managers and margins, and the returns leave the runway shared rather than owned.

The growth runway

The demand case rests on three compounding layers, and Nuvama's own filings quantify each. India's gross household savings reached about $790 billion by FY23, growing near 12% a year since FY20; financial savings have grown faster than physical ones, and inside financial savings the smallest, fastest-growing slice — shares and debentures — rose roughly 13x between FY12 and FY23 [3]. Mutual fund AUM stood at about $820 billion by June 2025 with monthly SIP inflows above $2.2 billion, yet AUM sits at just 18% of GDP against a world average of 74% [4].

The penetration gap is the heart of the case. Wealth under professional management in India is roughly 15% of financial wealth, versus about 75% in mature markets [5].

Sources: wealth under professional management, FY2024 Annual Report [6]; MF AUM to GDP, FY2025 Annual Report [7].

Management frames the same math plainly. On the Q3 FY24 call, CEO Ashish Kehair argued that over a ten-year horizon 20-25% industry growth is "easy": organized wealth management manages perhaps $180-240 billion of the country's $1.8-2.4 trillion of capital-market-linked wealth — a 10-15% penetration against 30-40% in China and 80-90% in developed markets — so a doubling-to-tripling of the underlying wealth combined with penetration rising toward 30% implies an industry roughly 4x larger in a decade [8]. He also characterized the sector as neither fully cyclical nor defensive: markets move allocations, but the underlying client wealth keeps compounding [9]. That nuance matters for a business whose largest profit pool still rides the capital-markets cycle (Wealth Economics).

Where growth is headed

The direction of travel, not just the size, is what a professional manager captures. Nuvama's management discussion points to four shifts, each visible in its own book.

Up the wealth pyramid, and beyond the metros. The number of working Indians earning over USD 10,000 grew at roughly 11% a year (2019-2023) against 0.8% for the overall population; term deposits above $18,000 compounded near 44% and supply of homes above $180,000 near 47% [10]. Affluent growth is now appearing beyond the top-30 cities, where households still self-manage or hold deposits — the conversion pool professional wealth managers target.

From product to portfolio, and into alternatives. Investors are moving from single-product bets toward multi-asset mandates, PMS, and alternatives. The alternatives pool — AIFs, private equity, private credit, real assets — is projected to grow about 5x over the decade, from roughly USD 480 billion to USD 2,500 billion, and the share of managed HNI wealth held in AIFs is expected to double from 8% (FY24) to 16% (FY34) [11] [12]. Wealth under professional management itself is projected to roughly triple, from about USD 280 billion to USD 850 billion, in five years [13].

Source: FY2025 Annual Report, management-discussion industry projections (company reports these global-comparison pools in US dollars) [14].

Financialization into recurring formats. Mutual fund AUM has tripled in five years to about 20% of GDP against over 100% in mature markets, aided by digital rails that let India leapfrog stages of market development [15]. This is the same shift toward recurring, managed-product fees that already drives Nuvama's own mix (Wealth Economics).

New product rails. SEBI's Specialised Investment Funds, effective April 2025, open a category between mutual funds and PMS/AIF — a fresh distribution and manufacturing lane for scaled players [16].

Globally, wealth management tends to grow three-to-five times the pace of the capital-markets industry it sits on — the leverage a manager gets from rising penetration on top of rising markets [17].

The competitive arena

A large, growing, high-return pool is precisely the kind that attracts entrants — which is where the runway stops being Nuvama's alone. The listed field spans four distinct models, and Nuvama competes against a different rival in each of its segments.

Source: market data as of 10 July 2026, as reported; peer set per company filings.

Nuvama's position is the integrated pure-play at scale: about $50 billion of client assets across wealth, asset services, capital markets, and asset management [18]. Its closest analogue is 360 ONE WAM, India's largest non-bank wealth manager, whose AUM including custody reached $67.9 billion in FY25 (up 24.5%), skewed to UHNI clients and a larger asset-management arm [19]. Anand Rathi Wealth is the pure product-distribution model — asset-light, $9.0 billion of AUM, no lending book — earning the highest returns in the group [20]. Motilal Oswal mirrors Nuvama's multi-segment shape but adds housing finance and a large proprietary book; Angel One and IIFL Capital compete on the broking and capital-markets flank rather than in private wealth.

The moat test

A durable premium requires the advantage to show up in numbers a competitor cannot easily copy — margins, returns, retention, or switching costs that hold. Two facts sit in tension.

On one side, returns are high across the entire field — the signature of a good industry more than a protected one. Nuvama earned a 28.1% return on equity in FY26 (31.5% in FY25); 360 ONE earned 20.7% (24.3% excluding goodwill, after an October 2024 equity raise); Anand Rathi, asset-light, has run above 40% [21] [22] [23].

Sources: Nuvama ROE, Q4 FY2026 investor presentation [24]; 360 ONE tangible ROE 24.3%, FY2025 Annual Report [25]; Anand Rathi, FY2025 Annual Report [26].

Nuvama's own management discussion names the mechanism that erodes such returns. It writes that the market's potential "has attracted multiple new entrants — domestic, global private banks and fintechs" and that competition for experienced relationship managers is "intensifying, pushing up acquisition and retention costs," pressuring margins for firms that cannot scale or differentiate [27]. The core producing asset in wealth management is the relationship manager, and RMs move — carrying clients with them — which caps switching costs at the platform level. Nuvama's own franchise shows the strain: roughly 30% of its Nuvama Wealth RMs are sub-one-year and still earning below their fixed cost (Wealth Economics). The two financial sponsors that have owned Nuvama — PAG, now selling to General Atlantic (Ownership and Governance) — are themselves evidence that capital is chasing these returns.

On the other side, scale compounds in ways a new entrant cannot short-cut. Nuvama's cost-to-income fell from about 70% to 56% as it scaled, lifting operating PAT to $117 million in FY26 [28]. Its asset-services (custody and clearing) arm is an infrastructure-like business that grew and posted record profit through a weak capital-markets year — a genuinely hard-to-replicate position few Indian peers hold (Wealth Economics). The management discussion's own conclusion is that the industry is consolidating toward larger, institutionalized players, and that "firms that professionalise quickly are likely to emerge as long-term winners" while others "consolidate or fail" [29].

The evidence points to a narrow moat, not a wide one: scale, an integrated product shelf, institutional clearing infrastructure, and a 30-year brand are real and quantified advantages, but they are advantages of degree in an industry whose economics invite well-funded imitation, and whose key asset can walk out the door. The read would widen if Nuvama's recurring, managed-product share and asset-services lead keep compounding faster than peers through a full market cycle; it would narrow if RM-cost inflation and yield competition — both flagged in Nuvama's own filings — compress the group's high returns toward the industry's cost of capital. For a value investor weighing a premium multiple against the demand of a margin of safety, the runway is real, but it is a runway many are cleared to use.

---

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

What the price is, and what sits beneath it

At $20.3 Nuvama is valued near $3.76bn — roughly 34x trailing and 29x forward earnings, and 8.7x book against a mid-20s return on equity. Two arm's-length marks sit below that price: the consensus target ($19.6), and the ~$3.4bn a control buyer, General Atlantic, is reportedly willing to pay for PAG's stake — a deal said to have stalled on the valuation gap the recent rally opened. The premium is real, but it is a sector rating, not a Nuvama outlier.

The economics (Wealth Economics), the owner (Ownership and Governance) and the runway (Industry and Rivals) are now established. This chapter puts a price on them, and asks what a value-minded buyer would have to pay to own the compounding with a cushion.

What the tape says today

Source: price as of 9-Jul-2026 (exchange data); FY26 profit after tax $109m and net worth $432m [1] [2]; multiples derived.

Nuvama earned $109m of consolidated profit in FY26 on $327m of revenue, with net worth of $432m at 31 March 2026 [3] [4]. Against a $3.76bn market capitalisation, that is 34.5x trailing earnings and 8.7x book. On consensus, the forward multiple compresses: nine analysts model earnings per share of $0.71 for FY27 and $0.84 for FY28, roughly 20% and 19% growth, which puts the stock at 28.7x FY27 and 24.2x FY28. The ratings below reference the same $20.3 price against each year's earnings.

Source: FY26 earnings [5]; FY27–FY28 consensus earnings per share (9 analysts); ratios derived.

The 8.7x book value multiple is the number that most rewards scrutiny, because Nuvama is a balance-sheet business — a lender and clearing house wrapped inside a fee franchise (Wealth Economics). A financial is worth book value scaled by how far its return on equity clears its cost of equity. Nuvama's statutory ROE was 25.3% in FY26 (28.1% on the company's operating basis, down from 31.5% in FY25 as capital markets softened) [6]. A mid-20s return does justify a book multiple well above one — but 8.7x is a demanding reading of how long that return holds.

A control buyer marks it lower

The most useful anchor is not a model; it is a transaction. PAG, which owns ~54% of Nuvama, is in advanced talks to sell that stake to General Atlantic for about $1.82bn [7]. That values the whole company near $3.4bn — about $18.2 a share — some 10% below the $3.76bn the public market assigns. And the negotiation is reportedly held up by exactly this: the gap that opened after Nuvama's stock rallied [8]. A disciplined control buyer, doing full diligence, is presently unwilling to pay the screen price.

Sources: General Atlantic mark derived from the reported ~$1.82bn for ~54% [9]; consensus targets (mean $19.6, range $17.1–$21.7) from 9 analysts; price as of 9-Jul-2026.

The sell-side agrees the price is full even without the deal. The mean 12-month target across nine analysts is $19.6 — below the $20.3 spot — with a $17.1 low and $21.7 high; Motilal Oswal, a "Buy", carries $19.5 [10]. A stock trading above its mean target and above the mark of a well-informed control acquirer is not, by any of those measures, offering a discount.

That reading exists because of how far and fast the stock has moved. On a split-adjusted basis (Nuvama split its shares 1:5 in December 2025 [11]), the price fell to about $12.2 at the end of March 2026 and has since risen about two-thirds to $20.3 — the run that opened the deal gap.

Source: exchange closing prices, post-split window (Dec 2025 – Jul 2026); split ratio 1:5 effective Dec 2025 [12].

General Atlantic is not a naive party here: it held roughly a 22% stake in 360 ONE (then IIFL Wealth) from 2015, so it knows what Indian wealth-management economics are worth [13]. Its reluctance to chase the rally is a data point a buyer should weigh alongside the multiple.

Mid-pack in an expensive sector

The word "premium" needs a benchmark, and against its listed peers Nuvama is not the expensive one. At 34.5x trailing earnings it sits in the middle of the group — richer than IIFL Capital's pure capital-markets business, close to Angel One and Motilal Oswal, and far below the asset-light distributors Anand Rathi and Prudent, which the market rewards with 55–89x for needing almost no balance sheet.

Sources: market capitalisations from current exchange prices; earnings, net worth and ROE derived from each company's reported FY2026 financials. 360 ONE's ROE is depressed by acquisition goodwill; Motilal Oswal's earnings include treasury and diversified segments, so its multiple is not a clean wealth comparison.

Where Nuvama does look full is book value. Its 8.7x is nearly double the 3.5–5.1x of the other balance-sheet operators — 360 ONE, Motilal Oswal, Angel One, IIFL Capital. Part of that gap is earned: Nuvama's 25.3% ROE is the highest of that balance-sheet cohort, and its earnings mix is tilting toward recurring wealth fees (Wealth Economics). But a doubling of the book multiple asks more of ROE durability than a mid-20s return, drifting down from 31.5%, comfortably supplies.

Sources: ROE and price/book derived from reported FY2026 financials and current market prices; bubble size is market capitalisation.

What 34x embeds

A balance-sheet financial is worth roughly (ROE − g) / (COE − g) times book, where g is sustainable growth and COE the cost of equity. Hold Nuvama's ROE at 25% and put the cost of equity near 14% — a reasonable level for a mid-cap Indian financial with cyclical earnings — and 8.7x book can only be reconciled by embedding perpetual growth close to that cost of equity, i.e. high-teens compounding that never fades. That is not impossible in a sunrise industry (Industry and Rivals), but it is the assumption the multiple rests on, and it is the one a drawdown would test.

The more useful version of the same arithmetic is the downside. The table below reads off the "fair" book multiple if the through-cycle settling point for ROE and growth turns out lower than today's — the scenario a value buyer underwrites against.

Source: derived, single-stage residual-income model at a 14% cost of equity; illustrative, not a forecast. It deliberately excludes the near-term growth premium, so it reads as a downside floor rather than a fair value.

The gap between 8.7x today and 2–5x in these settled-state scenarios is the growth premium the market is paying for — the value of Nuvama compounding at 20%-plus for years before the return fades. On forward earnings the same premium reads as a PEG near 1.5x (28.7x FY27 earnings against ~20% growth): not cheap, not extreme, and entirely dependent on the growth persisting. Dividends do little to close the gap — Nuvama pays out about 49% of operating profit [14], but at this price that is a yield near 1.5%. The return case is capital appreciation from compounding, not income.

Where a cushion would appear

Three independent marks — the consensus target, the control-buyer valuation, and the settled-state book multiples — all sit below the $20.3 price, and the near-term rating leaves little room for the cyclical half of earnings to disappoint (What Nuvama Is). On the reader's own terms, a margin of safety is not present at today's price; it would begin to appear nearer the $16.8–$18.1 zone where the control buyer and the street low converge, and would be clear only a further step below that — roughly where the stock traded through the first quarter of 2026.

That read has a real counter. Nuvama's compounding has been fast and its mix is improving: the recurring wealth engine grows in the 20–30s, Asset Services posted record profit through a weak capital-markets year, and a 25% ROE on a widening fee base can grow into a high multiple rather than de-rate to it (Wealth Economics). If FY27–FY28 earnings land near the $0.71–$0.84 consensus and the wealth mix keeps shifting, today's 29x forward becomes 24x on FY28 and the premium quietly amortises. What would change the read in the buyer's favour is concrete and checkable: the General Atlantic deal closing at or above the current price (a validation, not a discount), consensus FY27 earnings revised up rather than down, or a market drawdown resetting the entry point. What would harden the caution is the mirror image — the deal repriced or abandoned on the valuation gap, ROE continuing its drift below the mid-20s, or the transactional and broking base that still dominates client assets dragging blended economics as the cycle turns.

---

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Through the Cycle

Nuvama's profit splits into two engines: a structural wealth pool ($65m of FY26 pre-tax profit) that has compounded every year, and an Asset Services and Capital Markets pool ($92m, about 60% of operating profit) that rides the capital-markets cycle. In the last drawdown, FY23, the cyclical pool's profit fell about a third while the wealth engine absorbed it, so group return-on-equity has never fallen at scale — the untested assumption inside the 8.7x book multiple.

Two engines, one platform

Group operating pre-tax profit of $154m in FY26 comes from three divisions of very different character [1]. Wealth Management (Nuvama Wealth plus Nuvama Private) earned $65m and grew 23% [2][3]. Asset Services and Capital Markets earned $92m, the single largest pool, and fell 3% [4]. Asset Management remains a small loss (roughly negative $4m), still investing behind a mutual-fund and SIF build-out.

Sources: FY26 Investor Presentation, wealth PBT $37m + $28m [5][6] and ASCM PBT $92m [7]; FY21–FY24 segment PBT from FY24 Investor Presentation [8]; FY25 ASCM PBT $100m [9].

The wealth pool is the part Wealth Economics established as recurring and compounding; this chapter is about the other pool, and about what the two do together when markets turn. The audited accounts do not draw this line — Ind AS segment reporting folds Asset Services and Capital Markets into a single "Capital market" segment — so the decomposition is only visible in management's divisional disclosure.

What the last drawdown actually did

FY23 is the one genuine capital-markets downturn in the record: Indian equity issuance and institutional activity cooled after the 2021 boom. Its fingerprints are clear in the divisional numbers. The combined Asset Services and Capital Markets pre-tax profit fell from $28m in FY22 to $16m in FY23 — a 36% decline [10]. In the same year the wealth pool grew from $27m to $41m, up 65%, as the annuity book scaled through the weakness [11].

The net of those two moves is the important part. Group operating return-on-equity did not fall in FY23 — it edged up, from 16.6% to 17.8%, because the wealth engine was still in its steepest growth phase and swamped the cyclical hit [12]. Statutory ROE that year was lower, around 13.5%, weighed down by demerger and listing costs that have since dropped out; the operating figure is the cleaner read of underlying returns (derived from reported financials).

Source: FY26 Investor Presentation, operating ROE by year [13].

The record therefore contains one downturn, and in it the group's return rose. That is a real strength — but it is also why the trough is untested. The only ROE decline Nuvama has ever reported is FY26's step down from 31.5% to 28.1%, a peak-of-cycle normalisation rather than a drawdown [14]. What a mature-growth franchise does when a downturn arrives, at this size, has not happened yet.

The cyclical pool is less cyclical than it was

The other reason FY23 is an imperfect guide: the cyclical pool has changed shape. Inside Asset Services and Capital Markets sit two very different businesses. Capital Markets — institutional equities, investment banking, block deals, fixed-income origination — is the genuinely cyclical piece, a flow business whose revenue tracks market activity. Asset Services — custody, derivatives clearing and fund administration for 275-plus foreign and domestic institutional clients, on $14.0bn of assets under custody — is an annuity that management calls "infrastructure-like," and the FY26 numbers largely bear that out [15][16].

Source: FY26 Investor Presentation, Asset Services and Capital Markets journey over years [17].

FY26 is the cleanest demonstration of the difference. Capital Markets revenue fell 19%, from $89m to $68m, as issuance and secondary activity slowed [18]. Asset Services revenue rose 12%, from $77m to $82m, a record [19]. The annuity offset the flow decline, and the combined pool's profit slipped only 3% [20]. In FY23, Asset Services was a $19m business that dipped 8% with the market; by FY26 it is an $82m business whose custody assets barely moved even as Capital Markets rolled over. The cushion that did not exist at scale in the last downturn exists now.

That said, Asset Services is not fully weatherproof. Its revenue is tied to foreign- and domestic-institutional custody balances, which grow with flows into Indian equities and alternatives; a sustained risk-off phase that pulls assets out — not merely a quiet issuance year — would test it in a way FY26 did not. Its FY21–FY23 flatness ($23m to $23m to $19m) is a reminder that the "structural" growth is a recent, post-FY24 phenomenon, not a decade-long track record.

Sizing a trough

No model can price a drawdown Nuvama has not lived through, but the FY23 magnitude gives an honest anchor. The illustrative scenarios below hold Asset Services and Asset Management roughly flat and apply an FY23-style shock to the cyclical pool, with two assumptions about the wealth engine — that it stalls, or that it keeps growing as it did through FY23. They are arithmetic, not forecasts.

Source: illustrative; derived from FY26 divisional pre-tax profit and the FY23 drawdown magnitude (cyclical pool −36%) [21][22]; implied ROE on ~$500m equity, ~24% tax.

The illustrative trough lands in the high-teens to low-20s on operating ROE — a good business by any standard, but well below the 28% the market currently capitalises at 8.7x book (Margin of Safety). The result is most sensitive to one assumption: whether the wealth engine keeps growing into a downturn, as it did in FY23, or stalls once its own market-linked flows soften. Two of the wealth pool's own inputs are pro-cyclical — brokerage (11% of Nuvama Wealth revenue) and the transactional balances that still dominate client assets — so a severe drawdown would lean on wealth and the cyclical pool at once, and the "wealth flat" row is the more prudent planning case.

A third cyclical vector: the loan book

The lending book is the quieter pro-cyclical exposure. Nuvama Wealth's loans grew 76% to $549m in FY26, largely lending against securities [23]. In a rising market it earns net interest and deepens client relationships; in a sharp fall, collateral values drop, margin calls rise, and provisions can land exactly when the fee pools are weakest — the correlation that turns a diversified platform into a single bet at the wrong moment. The FY23 test predates most of this book, so it offers little comfort here. The asset-quality detail that would let a reader size the risk — loan-to-value bands, the split between lending-against-securities and promoter or ESOP financing, and any historical credit-loss experience — is not in the divisional disclosure, and remains the most material open question this chapter cannot close.

What would change the read

Management's cross-cycle framing is that "each business delivering profit CAGR of ~20% or above, across 2, 3, and 4-year horizons," and that FY26 "tested us across multiple fronts; macro uncertainty, volatile markets" while the platform stayed resilient [24]. The FY26 numbers support that claim at the level of a soft year: a 19% Capital Markets decline cost the group only 3% of its biggest profit pool. What they do not yet support is the harder claim the multiple embeds — that returns stay in the mid-20s through a genuine drawdown at maturity. Three things would resolve it: a Capital Markets revenue fall deeper than FY26's 19% and how far the combined pool's profit follows; whether Asset Services custody balances hold or bleed when flows reverse; and the loan book's first real credit cycle. Until one of those arrives, the trough remains an estimate, and the 8.7x book rests on it.

---

Figures converted from Indian rupees at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Loan Book

Nuvama runs a $535 million lending book against securities and margin, ~99.7% secured, that carries an expected-credit-loss provision of just 0.29% and a stated non-performing balance of $1,700 — effectively zero. That near-absence of losses is real, but it is a model output resting on collateral the filings never quantify, in a book that has never met a genuine equity drawdown at this scale. For a reader who screens out anything that could go bankrupt, this is where the balance-sheet risk lives.

A short, secured book that lends against listed collateral

The lending sits inside Nuvama Wealth Finance Limited and shows up on the consolidated balance sheet as one line, "Loans." At 31 March 2025 it was $537 million gross — $431 million of retail credit (loan against securities) plus $107 million of margin trading facility [1]. Both are lent against financial collateral — equity shares, mutual-fund units, bonds and AIF units [2]. Of the $537 million, $535 million was secured; the unsecured slice — mostly legacy ESOP financing — was $1.6 million, about 0.3% of the book [1].

Two features matter for how this book behaves under stress. It is short: every dollar of the $535 million net loan balance matures within twelve months, and $111 million falls due inside three months [3]. And it is callable — the facilities carry a right for the group to cancel or reduce them at one day's notice, and margining collateral is valued daily [4]. A lender who can re-price collateral every day and pull the loan within a day is structurally better placed than a term lender when markets fall.

Source: FY2025 Annual Report, Note 14 (FY24–FY25) [1]; FY2023 Annual Report, Note 14 (FY22–FY23) [5].

One point of arithmetic worth flagging early: on this consolidated measure the book did not grow in FY25 — it fell 6%, from $587 million to $537 million [1]. The "+76%" growth cited elsewhere in the report (Wealth Economics) is the Nuvama Wealth segment's loan line — $327 million to $543 million between FY25 and FY26 [6]. The two are different scopes: the segment figure is the HNI/affluent book alone; the consolidated Note-14 figure adds Nuvama Private's lending and the group's margin trading facility. The surge, in other words, is a FY26 event that lands after the last audited credit disclosure.

The provision is a model output, not an observed loss rate

The book's headline credit quality is close to pristine. At FY25, $537 million of gross loans classified as Stage I "high grade," with Stage II nil and Stage III — the credit-impaired bucket — at $1,700 [7]. The expected-credit-loss allowance was $1.55 million, or 0.29% of the book [8]. That is not a one-year artefact: coverage has sat in a 0.26%–0.29% band every year since FY22, and the impaired balance has never exceeded $22,000 [5].

Source: FY2025 Annual Report, Note 14.A [7], [8]; FY2023 Annual Report, Note 14.A [5].

The reason the provision is so small is mechanical, and the annual report states it plainly. Because the business lends against securities, the expected-credit-loss model applies a Basel-style haircut to the collateral, treats only the exposure above the haircut collateral as at risk, and assigns loss-given-default of 65% to the unsecured portion alone [9]. On a book that is 99.7% secured, that construction all but guarantees a near-zero provision: the model assumes the haircut collateral will be there and can be realised. The 0.29% is therefore best read not as an observed loss experience but as a statement about how well-collateralised the book is assumed to be — and the assumption has only ever operated in the rising or sideways equity market of FY21 through FY26.

What the disclosure does not tell you

For a reader trying to size the tail, the gap in the record matters as much as the numbers in it. The filings name the collateral types and describe the haircut methodology, but they do not disclose the one thing that would let an outsider judge the cushion: the fair value of collateral held against the loan book, the distribution of loan-to-value ratios, or a concentration table by borrower or by pledged stock. Management asserts there is "no significant concentration with regard to single/group client and industry," but publishes no figures behind it [9]. Collateral, the notes confirm, is not recorded on the balance sheet unless repossessed [4]. Nor do the quarterly calls fill the gap: management's collateral commentary is about the custody and clearing business, not the lending book. The reader is left to take the coverage ratio on trust.

Collateral realisation is not automatic — the Anugrah matter

The record contains one concrete demonstration that liquidating collateral can create losses even when the loan ledger shows none. The FY2025 audit opinion carries an Emphasis of Matter — an item the auditor thought material enough to flag while leaving the opinion unmodified — pointing to two subsidiary disputes now before the Supreme Court over the liquidation of collateral [10].

The larger of the two runs through the clearing subsidiary, Nuvama Clearing Services. When a trading member, Anugrah, defaulted on its margin obligations in early 2020, the subsidiary liquidated $53.6 million of Anugrah's collateral to cover the shortfall. NSE Clearing later held that the liquidation swept up collateral beyond the margin shortfall — reaching securities belonging to Anugrah's end-clients — and ordered the securities reinstated; the Securities Appellate Tribunal upheld that order in December 2023, and the subsidiary's appeal to the Supreme Court is pending. No provision has been made [11].

Source: FY2025 Annual Report, Independent Auditor Report [10] and Note 56 [11]; equity per FY2025 balance sheet.

The read: a manageable book on an untested assumption

Weighing the two sides, the loan book is not, on the evidence, a plausible path to insolvency — the risk the value-investor reader screens for. It is 99.7% secured, callable at a day's notice, matures entirely within a year, and has been de-risked over time: the unsecured share fell from 3.7% of the book in FY23 to 0.3% in FY25 as legacy ESOP and IPO-funding exposures ran off [5]. Even through the FY23 correction it produced no meaningful impairment. Against Nuvama's $407 million of FY25 equity, a book this structure would have to lose an implausible fraction of its collateral value, on top of failed margin calls, to threaten solvency.

The honest qualification is that the comfort rests on an assumption that has not been tested. The near-zero provision is what the model produces when collateral is assumed realisable at haircut value; the Anugrah matter is a live, cited instance of collateral realisation going wrong; and the fastest-growing, least-seasoned vintage of the book — the FY26 surge — postdates the last audited staging. What would change the read is observable and specific: Stage II migration or a rising coverage ratio in the FY2026 annual report's Note 14.A; the first disclosure of loan-to-value or collateral-coverage figures on the enlarged book; an adverse Supreme Court outcome on the Anugrah appeal; or a genuine, sharp equity drawdown that lets an outsider watch, for the first time at this scale, whether the collateral cushion holds.